MCOLN1 and triple-negative breast carcinoma: TRPML1 was specifically upregulated in triple-negative breast cancer (TNCB), which regulates TNBC development through controlling mTORC1 activity and the release of lysosomal ATP, while genetic downregulation or pharmacological inhibition of TRPML1 suppressed the growth of TNBC [153].